ROCHESTER, N.Y. PharmaSmart International announced Monday that it is partnering with AstraZeneca Canada to deliver tools and programs to pharmacists, physicians and patients around the improved management of hypertension.
The partnership program positions community pharmacy at the front lines of disease state management, and will involve a select group of Canadian retail pharmacy participants, the company stated.
“The AstraZeneca Canada partnership further strengthens our commitment to the retail pharmacy and the patient community, and aligns well with our mission and core competency.,” stated Ashton Maaraba, PharmaSmart’s SVP/GM, global sales and operations. “Hypertension is the No. 1 contributor to premature death in North America. By combining our technology and programs with the strength and expertise of companies like AstraZeneca Canada, we can better combat this deadly disease.”